To expand patient access and enhance diagnostic capabilities, Labcorp has opened a new state-of-the-art diagnostics laboratory in Chantilly, Virginia. As Labcorp’s largest regional diagnostics branch, the facility supports more than 200 employees and processes over 26,000 specimens each day. It offers expanded services, including histology and cytology, and features modern workspaces designed to improve efficiency.
Last week, Labcorp announced our 2024 fourth quarter and full-year results, demonstrating strong performance across our core businesses and continued progress on our growth strategy. Click to read the full release.
Beekeeping is the buzz around a number of our sites, and recently Labcorp hosted its first honey competition featuring honey cultivated from our labs in Geneva, Switzerland; Mechelen, Belgium; Münster, Germany; and Huntingdon and Eye in the United Kingdom. Congratulations to our winners: ▶️ Eye – Best Tasting Honey, First Place ▶️ Münster – Best Tasting Honey, Second Place ▶️ Geneva – Best Branding and Design While these sites took home the awards, we celebrate the great work of our teams to foster healthy ecosystems around the globe.
This National Health Center Week, we’re recognizing the community health centers working tirelessly to provide quality, affordable care to our communities. Labcorp is proud to partner with these centers to expand access and improve health. Learn more about our work to close gaps in care.
We are proud to have earned a top score on the 2024 Disability Equality Index®, and to be recognized by Disability:IN as a #BestPlaceToWork24 for #DisabilityInclusion.
Labcorp is proud to be named as one of TIME’s World’s Most Sustainable Companies of 2024. This recognition reflects our commitment to sustainable practices that positively impact the planet and is a testament to all that our employees do to help us create a healthier world. Read more about our sustainability initiatives in our 2023 Corporate Responsibility Report.
We’re proud to announce new strategic service offerings within our precision oncology portfolio. These enhancements, which include expansions of select comprehensive genomic profiling services, demonstrate our commitment to partnering with biopharmaceutical companies to advance cancer research and patient care both in the U.S. and across the globe.
Alongside our global PRIDE employee resource group (ERG), Labcorp proudly supports our LGBTQIA+ employees and allies in recognizing and celebrating #Pride Month 2024. Join us in acknowledging the vital contributions of our LGBTQIA+ communities and their role in making Labcorp a place where diversity thrives. Together, we create a workplace where everyone can thrive with PRIDE.
At Labcorp, we are committed to representing, expanding and elevating the diverse voices across all levels of our organization. This year, we are pleased to be listed on Forbes America’s Best Employers for Diversity alongside organizations that continue to prioritize diversity, equity and inclusion efforts.
We're excited to announce phi, a prostate health index test that provides greater clarity in assessing prostate cancer risk, helping minimize false positives and unnecessary biopsies. Learn more in our phi brochure about how the test can help you confidently manage prostate health.
Check out your Company Bowl for anonymous work chats.
